Reset filters
  • 28 February 2007

CROI: Integrase inhibitor raltegravir (MK-0518) doubles HIV suppression in treatment-experienced patients at 16 weeks

Read the article
  • 27 February 2007

CROI: MSF reports good responses on PI-based second-line ART regimens even though switch from failing regimens comes late

Read the article
  • 27 February 2007

CROI: Growth hormone stimulant TH9507 safe and effective in HIV lipodystrophy

Read the article
  • 27 February 2007

CROI: Alendronate effectively treats bone loss in men and women with HIV

Read the article
  • 27 February 2007

CROI: Lower CD4 count on HIV treatment predicts higher risk of cancers, liver, kidney, cardiovascular disease

Read the article
  • 27 February 2007

CROI: Efavirenz-based ART more effective than nevirapine-based ART as first-line therapy in Southern Africa

Read the article
  • 27 February 2007

CROI: SMART analysis reveals slightly elevated risk of cardiovascular disease in people who interrupt therapy

Read the article
  • 22 February 2007

Health Canada issues warning on use of Baraclude alone in HIV/hepatitis B coinfected

Read the article
  • 20 February 2007

Merck announces plans for licensing Atripla widely in developing world

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.